Facebook
Twitter
Telegram
Report an ErrorKala Pharmaceuticals Financial Ratios 2011-2024 | KALA
Annual Financial Ratios Kala Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.5 | -0.5 | -0.0 | -4.0 | -2.3 | -2.1 | -2.4 | - | - | - | - | - | - |
P/S |
- | 5.8 | 0.1 | 65.4 | 35.0 | - | - | - | - | - | - | - | - |
EPS |
-17.4 | -29.5 | -108.3 | -2.0 | -2.8 | -2.5 | -6.1 | -28.1 | -14.9 | - | - | - | - |
EV (Enterprise Value) |
16.9 M | 19.9 M | 32.1 M | 461 M | 252 M | 88 M | 14.7 M | 88.5 M | 65.1 M | - | - | - | - |
EBITDA per Share |
-16.2 | -53.4 | -98.2 | -1.7 | -2.55 | -2.38 | -5.73 | - | - | - | - | - | - |
EV/EBITDA |
-0.7 | -4.4 | -2.3 | -0.7 | -0.2 | - | - | - | - | - | - | ||
PEG |
-0.0 | -0.0 | - | -0.38 | -0.21 | 0.04 | -0.01 | - | - | - | - | - | - |
P/B |
2.6 | 1.2 | 0.1 | 4.2 | 7.2 | 1.4 | 1.1 | - | - | - | - | - | - |
P/CF |
-0.7 | -0.3 | -0.0 | -4.5 | -2.3 | -2.6 | -3.0 | - | - | - | - | - | - |
ROE % |
-562.35 | -236.23 | -848.64 | -104.33 | -317.75 | -63.57 | -47.07 | - | - | - | - | - | - |
ROA % |
-75.42 | -51.63 | -102.28 | -47.08 | -61.14 | -30.20 | -36.35 | - | - | - | - | - | - |
ROCE % |
-83.32 | -133.65 | -127.68 | -48.26 | -68.10 | -31.73 | -39.22 | - | - | - | - | - | - |
Current Ratio |
1.2 | 1.3 | 1.1 | 7.7 | 4.3 | 10.4 | 8.0 | - | - | - | - | - | - |
DSO |
- | 719.5 | 405.1 | 565.3 | 787.1 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | 601.5 | 844.9 | - | - | - | - | - | - | - | - |
DPO |
- | - | - | 198.3 | 457.7 | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 719.5 | 405.1 | 1166.9 | 1632.0 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 719.5 | 405.1 | 968.5 | 1174.3 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Kala Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-4.2 | - | -3.41 | -4.36 | -6.99 | - | 19.39 | -18.92 | -22.18 | - | -21.41 | -0.57 | -0.49 | -0.55 | -0.5 | -0.42 | -0.54 | -0.63 | -0.68 | -0.7 | -0.75 | -0.76 | -0.63 | -0.6 | -0.46 | -0.46 | -0.56 | -9.3 | -8.26 | -7.11 | -8.18 | -8.34 | -4.45 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-4.22 | - | - | - | -5.61 | - | -9.41 | -17.3 | -20.7 | - | -19.3 | -0.44 | -0.46 | - | -0.45 | -0.37 | -0.49 | - | -0.61 | -0.65 | -0.7 | - | -0.62 | -0.58 | -0.45 | - | -0.52 | -8.03 | -8.04 | - | -8.06 | -8.04 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-391.90 | -198.70 | -3202.11 | -6127.96 | -5979.34 | -2290.91 | -2336.67 | 620.98 | 488.58 | -116.77 | -147.88 | -130.07 | -110.08 | -104.33 | -147.17 | -197.28 | -254.20 | -317.75 | -267.82 | -204.63 | -138.32 | -63.57 | -52.14 | -71.76 | -80.96 | -81.08 | -58.93 | 3.78 | 44.12 | 55.00 | 45.44 | 17.21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-66.40 | -49.91 | -15.99 | 32.18 | 14.76 | -28.68 | -43.19 | -91.63 | -75.49 | -44.68 | -58.72 | -56.82 | -50.40 | -47.08 | -47.27 | -49.67 | -54.59 | -61.14 | -58.32 | -50.36 | -41.54 | -30.20 | -28.48 | -47.95 | -59.13 | -62.39 | -70.82 | -97.76 | -112.57 | -104.19 | -86.07 | -32.60 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-80.42 | -53.04 | -85.09 | -99.90 | -132.82 | -121.14 | -136.78 | -120.38 | -85.85 | -44.48 | -57.44 | -54.75 | -50.09 | -33.73 | -50.38 | -54.06 | -60.69 | -52.51 | -60.11 | -51.06 | -40.88 | -20.18 | -29.55 | -31.33 | -33.69 | -28.26 | -15.70 | 6.23 | 28.14 | 24.99 | 24.99 | 12.43 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.1 | 1.1 | 1.2 | 1.4 | 1.5 | 1.3 | 1.0 | 0.7 | 0.9 | 1.1 | 1.5 | 1.6 | 1.9 | 1.8 | 1.8 | 1.8 | 1.8 | 1.2 | 1.2 | 1.2 | 1.2 | 1.9 | 1.9 | 1.9 | 1.9 | 4.3 | 4.3 | 4.3 | 4.3 | 3.0 | 3.0 | 3.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | 1522.1 | 583.2 | 943.3 | - | 364.3 | 359.9 | 304.7 | 391.6 | 394.8 | 1052.1 | 901.7 | 894.2 | 727.2 | 512.9 | 380.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1655.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1507.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | 1522.1 | 583.2 | 943.3 | - | 364.3 | 359.9 | 304.7 | 391.6 | 394.8 | 1052.1 | 901.7 | 894.2 | 727.2 | 512.9 | 2035.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | 1522.1 | 583.2 | 943.3 | - | 364.3 | 359.9 | 304.7 | 391.6 | 394.8 | 1052.1 | 901.7 | 894.2 | 727.2 | 512.9 | 528.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency